Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Needling with topical celecoxib cream for keloid lesions
IRCT20240321061344N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of celecoxib in keloid, sponsored by Mashhad University of Medical Sciences. Primary endpoints: POSAS score change, Dermoscopic pigmentation change and 1 more. Started Apr 2024; status: completed.
02
Drugs
celecoxib
03
Conditions
keloid
Beyond the preview
Go deeper on IRCT20240321061344N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240321061344N1.